UA120762U - DIAZEPAM MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION - Google Patents
DIAZEPAM MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTIONInfo
- Publication number
- UA120762U UA120762U UAU201708004U UAU201708004U UA120762U UA 120762 U UA120762 U UA 120762U UA U201708004 U UAU201708004 U UA U201708004U UA U201708004 U UAU201708004 U UA U201708004U UA 120762 U UA120762 U UA 120762U
- Authority
- UA
- Ukraine
- Prior art keywords
- diazepam
- compound
- formula
- spasmolitic
- action
- Prior art date
Links
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003529 diazepam Drugs 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 230000002048 spasmolytic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000000730 antalgic agent Substances 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-UHFFFAOYSA-N 2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol Chemical compound OCC1OC(OC2C(O)C(O)C(O)OC2CO)C(O)C(O)C1O GUBGYTABKSRVRQ-UHFFFAOYSA-N 0.000 abstract 1
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000001341 hydroxy propyl starch Substances 0.000 abstract 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 abstract 1
- 239000003326 hypnotic agent Substances 0.000 abstract 1
- 230000000147 hypnotic effect Effects 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 229950000688 phenothiazine Drugs 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 239000000454 talc Substances 0.000 abstract 1
- 229910052623 talc Inorganic materials 0.000 abstract 1
- 235000012222 talc Nutrition 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Лікарський препарат знеболювальної, снодійної та седативної дії, який включає сполуку за формулою І: EMBED ISISServer , (І) причому лікарський препарат застосовується у формі таблеток, причому кожна таблетка містить 5 мг сполуки за формулою І, де сполука за формулою І є діазепамом, допоміжні речовини вибирають як щонайменше одну речовину з ряду взаємозамінюваних речовин: лактоза, моногідрат, гідроксипропілкрохмаль, целюлоза мікрокристалічна, кремнію діоксид, тальк, магнію стеарат, підсилюючий засіб вибирається з ряду: фенотіазин, анальгетики, інгібітори МАО та антидепресантів.An analgesic, hypnotic and sedative drug comprising a compound of formula I: EMBED ISISServer, (I) wherein the drug is administered in tablet form, each tablet containing 5 mg of a compound of formula I, wherein the compound of formula I is diazepam, ancillary substances are selected as at least one substance from a number of interchangeable substances: lactose, monohydrate, hydroxypropyl starch, cellulose microcrystalline, silicon dioxide, talc, magnesium stearate, enhancing agent is selected from the range of: phenothiazine, analgesics bitory antidepressants and MAO.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201708004U UA120762U (en) | 2017-08-01 | 2017-08-01 | DIAZEPAM MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201708004U UA120762U (en) | 2017-08-01 | 2017-08-01 | DIAZEPAM MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA120762U true UA120762U (en) | 2017-11-10 |
Family
ID=60258436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201708004U UA120762U (en) | 2017-08-01 | 2017-08-01 | DIAZEPAM MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA120762U (en) |
-
2017
- 2017-08-01 UA UAU201708004U patent/UA120762U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201407947WA (en) | Compressible-coated pharmaceutical compositions and tablets and methods of manufacture | |
| MX2009004861A (en) | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor. | |
| AR079208A2 (en) | INHIBITORS OF THE ACTIVITY OF PROTEIN THYROSINE KINASE, COMPOSITION AND USE OF SUCH INHIBITORS FOR THE PREPARATION OF A MEDICINAL PRODUCT TO TREAT A DISEASE, DISORDER OR OPHTHALMIC CONDITION | |
| MX377251B (en) | CONTROLLED-RELEASE DOSAGE FORMS FOR HIGH-DOSE, WATER-SOLUBLE, HYGROSCOPIC DRUG SUBSTANCES. | |
| AU2007211091A8 (en) | Drug delivery systems comprising weakly basic selective serotonin 5-HT3 blocking agent and organic acids | |
| RS51330B (en) | Stable pharmaceutical formulations of montelukast sodium | |
| WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
| PT1239857E (en) | DOUBLE LIBERATION COMPOSITIONS OF A CYCLO-OXYGENASE-2 INHIBITOR | |
| TW200738228A (en) | Neramexane modified release matrix tablet | |
| AR069031A1 (en) | COMPOSITION | |
| EA200801926A1 (en) | TABLETS OF PARACETAMOL WITH FAST DELIVERY | |
| RS52374B (en) | Pharmaceutical forms with improved pharmacokinetic properties | |
| NO20074109L (en) | Intravenous formulations of PDE-5 inhibitors | |
| WO2018005519A3 (en) | Cancer treatment combinations | |
| PH12020550815A1 (en) | Delayed release deferiprone tablets and methods of using the same | |
| MA29278B1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING AN INDOLYLMALEIMIDE DERIVATIVE | |
| CN106029637A (en) | Novel compositions | |
| RU2013154355A (en) | METHOD FOR TREATING MESOTHELIOMA INHIBITOR PI3K | |
| ZA202400988B (en) | Aak1 inhibitor and use thereof | |
| PE20131035A1 (en) | NEVIRAPIN FORMULATION OF PROLONGED RELEASE | |
| RU2016103764A (en) | STABILIZED PHARMACEUTICAL MEDICINES CONTAINING ATRASENTAN | |
| JP2017523149A5 (en) | ||
| UA120762U (en) | DIAZEPAM MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION | |
| HUP0300378A2 (en) | Oxazolidinone tablet formulation and their preparation | |
| MA31227B1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING PHLOROGLUCINOL AND PARACETAMOL. |